Tris Pharma


Perrigo and Tris Pharma Launch Store Brand Version of Delsym

Allegan-based Perrigo Co. and Tris Pharma Inc. announced the commercial launch of a major new store brand product. The new product is equivalent to Delsym extended-release oral liquid suspension containing dextromethorphan polistirex and will be marketed under major U.S. retailer and wholesalers’ store brands or own label brands.

WWJ Newsradio 950–08/27/2012


Perrigo Announces FDA Approval Of Generic Delsym

Perrigo Co. (Nasdaq: PRGO) announced that the United States Food and Drug Administration has granted final approval to Tris Pharma for its abbreviated new drug application for Dextromethorphan Polistirex Extended-Release Oral Suspension, the store brand equivalent to Reckitt Benckiser’s Delsym suspension.

WWJ Newsradio 950–05/31/2012